# Cannabis and Digestive Health: Understanding Clinical Risks > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/digestive-complications-cannabis-use-clinical-risks/ > **Published:** 2026-04-10T22:30:17-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:25:35-04:00 > **Clinical Summary:** Explore digestive complications cannabis use can cause, including cannabinoid hyperemesis syndrome and related clinical risks for patient care. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic [Cannabinoid Hyperemesis](https://cedclinic.com/cannabis-hyperemesis-syndrome-virginia-er-cases-surge/) SyndromeGi EffectsThcAdverse EffectsClinical Recognition Why This Matters Digestive complications from [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) represent an underrecognized clinical challenge that physicians across specialties are increasingly encountering. Understanding these risks is essential for proper patient counseling and differential diagnosis in patients presenting with GI symptoms. Clinical Summary [Cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) can produce several digestive complications, most notably [cannabinoid hyperemesis](https://cedclinic.com/cannabis-hyperemesis-syndrome-virginia-er-cases-surge/) syndrome (CHS) characterized by cyclic vomiting and compulsive hot bathing behavior. The endocannabinoid system’s role in gut motility and nausea regulation creates both therapeutic potential and risk for adverse effects. Chronic high-THC use appears particularly associated with these complications, though the exact prevalence and risk factors remain incompletely characterized. Recognition is challenging because symptoms can be paradoxical to cannabis’s typical antiemetic effects. Dr. Caplan’s Take “I see patients with undiagnosed CHS regularly – the hot shower behavior is pathognomonic but often overlooked. The key clinical pearl is that while cannabis typically reduces nausea, in susceptible individuals chronic use can flip this benefit into severe hyperemesis.” Clinical Perspective 🧠 Clinicians should maintain high suspicion for CHS in young adults with cyclic vomiting, especially if they describe relief from hot showers or baths. A thorough cannabis use history is essential for any unexplained GI symptoms. [Patient education](https://cedclinic.com/medical-cannabis-patient-education-basics/) should include discussion of these risks alongside therapeutic benefits, particularly for those considering high-THC products for chronic use. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Cannabis%20and%20Digestive%20Health%3A%20Clinical%20Risks%20-%20Medscape%20%40drcaplan&url=https%3A//www.medscape.com/viewarticle/cannabis-and-digestive-health-clinical-risks-2026a1000b1g)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.medscape.com/viewarticle/cannabis-and-digestive-health-clinical-risks-2026a1000b1g)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Cannabis%20and%20Digestive%20Health%3A%20Clinical%20Risks%20-%20Medscape%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.medscape.com/viewarticle/cannabis-and-digestive-health-clinical-risks-2026a1000b1g)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.medscape.com/viewarticle/cannabis-and-digestive-health-clinical-risks-2026a1000b1g](https://www.medscape.com/viewarticle/cannabis-and-digestive-health-clinical-risks-2026a1000b1g) Table of Contents - [FAQ](#FAQ)[What is Cannabinoid Hyperemesis Syndrome (CHS)?](#What_is_Cannabinoid_Hyperemesis_Syndrome_CHS) - [What are the main symptoms of CHS?](#What_are_the_main_symptoms_of_CHS) - [Who is at risk for developing CHS?](#Who_is_at_risk_for_developing_CHS) - [How is CHS diagnosed and treated?](#How_is_CHS_diagnosed_and_treated) - [Can CHS be prevented?](#Can_CHS_be_prevented) - [Related](#Related) ## FAQ #### What is Cannabinoid Hyperemesis Syndrome (CHS)? Cannabinoid Hyperemesis Syndrome is a condition characterized by cyclic episodes of nausea, vomiting, and abdominal pain in chronic cannabis users. It typically develops after prolonged, heavy use of THC-containing cannabis products. #### What are the main symptoms of CHS? The primary symptoms include severe nausea, repeated vomiting episodes, and abdominal cramping. Many patients also experience relief from hot showers or baths during acute episodes. #### Who is at risk for developing CHS? CHS primarily affects long-term, heavy cannabis users who consume THC regularly over months or years. The condition is more commonly reported in areas where cannabis use has increased or been legalized. #### How is CHS diagnosed and treated? Diagnosis is typically clinical, based on patient history of [chronic cannabis use](https://cedclinic.com/cannabis-tolerance-behavioral-models/) and characteristic symptoms. The most effective treatment is complete cessation of cannabis use, though supportive care may be needed during acute episodes. #### Can CHS be prevented? The only proven way to prevent CHS is to avoid chronic, heavy cannabis use. Patients using [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) should be aware of this potential adverse effect and monitor for early symptoms. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabis hyperemesis syndrome is on the rise: What symptoms to watch for – KGET.com](https://cedclinic.com/cannabis-hyperemesis-syndrome-clinical-overview/) Learn about the increasing cases of cannabinoid hyperemesis syndrome and key symptoms to identify this condition early. [Read More](https://cedclinic.com/cannabis-hyperemesis-syndrome-clinical-overview/) [Why Some Cannabis Users Get CHS — And Most Don't with Codi Peterson](https://cedclinic.com/cannabinoid-hyperemesis-syndrome-clinical-relevance/) Explore factors influencing why cannabinoid hyperemesis syndrome affects some cannabis users and not others. [Discover Insights](https://cedclinic.com/cannabinoid-hyperemesis-syndrome-clinical-relevance/) [Screaming, vomiting, and daily weed: The rise of 'scromiting' among chronic cannabis users](https://cedclinic.com/cannabinoid-hyperemesis-syndrome-clinical-overview/) Understand the severe vomiting disorder linked to [chronic cannabis use](https://cedclinic.com/cannabis-tolerance-behavioral-models/) and its clinical implications. [Learn More](https://cedclinic.com/cannabinoid-hyperemesis-syndrome-clinical-overview/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).